CITADEL ADVISORS LLC 13D and 13G filings for Immuneering Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:15 pm Sale | 2024-09-30 | 13G | Immuneering Corporation IMRX | CITADEL ADVISORS LLC | 2,672 0.000% | -2,075,420 (-99.87%) | Filing |
| 2024-02-14 4:57 pm Sale | 2023-12-31 | 13G | Immuneering Corporation IMRX | CITADEL ADVISORS LLC | 2,078,092 7.100% | -63,405 (-2.96%) | Filing |
| 2023-02-14 08:14 am Purchase | 2022-12-31 | 13G | Immuneering Corporation IMRX | CITADEL ADVISORS LLC | 2,141,497 8.100% | 83,349 (+4.05%) | Filing |
| 2022-02-14 06:22 am Sale | 2021-12-31 | 13G | Immuneering Corporation IMRX | CITADEL ADVISORS LLC | 2,058,148 7.800% | -4,528 (-0.22%) | Filing |
| 2021-08-13 4:02 pm Purchase | 2021-08-03 | 13G | Immuneering Corporation IMRX | CITADEL ADVISORS LLC | 2,062,676 8.000% | 2,062,676 (New Position) | Filing |